DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Global Health Limited — Analyst/Investor Meet Para A-XBRL

NSE 25 Aug·25 Aug 2026, 9:19 am

Global Health

Global Health Limited has informed the stock exchanges that it will hold an Analyst and Institutional Investor Meet. This meeting is scheduled for a specific date and will cover the Para A-XBRL format, which is a standard for financial reporting. The company is using this platform to communicate directly with market experts and large investors.

For investors, this event is significant as it provides an opportunity to gain clarity on the company's future strategy and financial outlook. Management will likely discuss their performance and plans, which can help in assessing the stock's potential. It is a chance for the market to understand the company's direction better.

Investors should watch for any updates regarding the agenda and the management's commentary on market conditions. This information can be crucial for making informed decisions about the stock. Keep an eye on the company's official announcements for more details.